1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

‘The world regenerative medicine revenues will reach $8.84bn in 2021’ says new Visiongain report

. A new report by visiongain, a London-based business information company, predicts that world regenerative medicine revenues will reach $8.84bn in 2021. That market generated $0.82bn in 2010.

 
PRLog - Aug. 5, 2011 - LONDON, U.K. -- Novel treatment options are in increasing demand as a result of growing disease prevalence worldwide. Regenerative medicine offers the opportunity to treat and cure many health disorders, including cancers and cardiovascular diseases. The regenerative medicine market will grow rapidly this decade, driven by the approval of new tissue engineered products, stem cell treatments and gene therapies. Growth will be most rapid in emerging markets, visiongain’s analysis shows.

Richard Lang, pharmaceutical industry analyst, said: “The world regenerative medicine market will benefit most from the entry of new products, especially in the US and Europe. Challenges in moving products from bench to bedside must still be overcome, however. Regulatory hurdles, scaling up manufacturing and product reimbursement will be the most prominent of these challenges from 2011 onwards.”

In 2010, autologous chondrocyte implantations and skin substitutes for diabetic foot ulcers constituted the largest sectors of the regenerative medicine market. These sectors will remain important, with aging world populations and rising diabetes prevalence, the report notes. Development of new products will lead to the greatest market growth, however. Stem cell and gene therapies targeting cardiovascular disorders represent the most promising products candidates from 2011 to 2021.

Visiongain forecasts that the overall regenerative medicine market will grow rapidly to 2021. Experience gained from the past two decades will quicken the pace of product approvals in the next ten years. The future of regenerative medicine is promising, as a result of increasing demand in many therapeutic areas and improved product development techniques, the published report concludes. This new study adds to visiongain’s wide range of analytical reports in healthcare and other industry areas.  

For sample pages of the report please click on:

http://www.visiongain.com/Report/652/Translational-Regene...

To request an exec summary o the report please contact Sara Peerun on:

Email: sara.peerun@visiongainglobal.com
Tel: +44 0207 3366100
Web: www.visiongain.com


Table of Contents
1.   Executive Summary

2. Translational Regenerative Medicine: An Introduction

3. The Global Regenerative Medicine Market 2011-2021

4. Leading Regenerative Medicine Companies

5. Leading Applications for Regenerative Medicine 2011-2021

6. Trends in Translational Regenerative Medicine 2011-2021

7. Regional Analysis of the Regenerative Medicine Market 2011-2021

8. Expert Opinions from Our Industry Survey

9. Conclusions


ENDS

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Pharmaceutical, Telecoms, Energy, Defence and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

# # #

Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Pharmaceutical, Telecoms, Energy, Defence and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.

--- End ---

Click to Share

Contact Email:
***@visiongain.com Email Verified
Source:Visiongain
Phone:+44 020 7336 6100
Zip:EC1V 2QY
Location:London - London - United Kingdom
Industry:Health, Science, Medical
Tags:drugs, medicines, revenue, regenerative medicine, pharmaceutical, Healthcare
Shortcut:prlog.org/11613056
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Trending News...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share